AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Halozyme Therapeutics, Inc.

$128.95 +$58.64 (+83.40%)
NASDAQ · 02 Nov 2026 21:00 UTC
Previous Close
$130.91
Day Range
$127.52$131.89
Year Range
$61.23$134.00
Market Cap
14.64B
AVG Volume
2.16M
Trailing/Forward PE
36.63/12.39
PEG ratio
1.17
Dividend Yield
-
Next Earnings Date
2026-11-05
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HALO Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q21.66B
26 Q11.51B
25 Q41.4B
25 Q31.24B
25 Q21.18B
25 Q11.08B
24 Q41.02B
24 Q3947.36M
24 Q2873.3M
24 Q1862.99M
Net Income (USD) · TTM
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HALO Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2413.6M
26 Q1348.84M
25 Q4316.89M
25 Q3595.49M
25 Q2557.28M
25 Q1485.36M
24 Q4444.09M
24 Q3392.47M
24 Q2337.29M
24 Q1318.8M
Operating Income (USD) · TTM
0250M500M750M1B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HALO Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2944.49M
26 Q1859.27M
25 Q4816.29M
25 Q3737.4M
25 Q2682.67M
25 Q1597.47M
24 Q4551.48M
24 Q3477.01M
24 Q2402.09M
24 Q1379.31M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: HALO

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

Halozyme Therapeutics, Inc.
HALO
Stockpicker

Video analysis: HALO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: HALO

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.